On June 22, Matthias Bodenstedt, Chief Financial Officer of MoonLake Immunotherapeutics (NASDAQ:MLTX), sold 39,120 common shares in an open-market transaction valued at approximately $862,000, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results